39 related articles for article (PubMed ID: 2095129)
1. Chelators affecting iron absorption in mice.
Kontoghiorghes GJ
Arzneimittelforschung; 1990 Dec; 40(12):1332-5. PubMed ID: 2095129
[TBL] [Abstract][Full Text] [Related]
2. Toxicity Studies of Ethyl Maltol and Iron Complexes in Mice.
Li Z; Lu J; Wu C; Pang Q; Zhu Z; Nan R; Du R; Chen J
Biomed Res Int; 2017; 2017():2640619. PubMed ID: 28197411
[TBL] [Abstract][Full Text] [Related]
3. The Puzzle of Aspirin and Iron Deficiency: The Vital Missing Link of the Iron-Chelating Metabolites.
Kontoghiorghes GJ
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791185
[TBL] [Abstract][Full Text] [Related]
4. The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency.
Kontoghiorghes GJ
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731873
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 3-hydroxypyridin-4-one derivatives bearing benzyl hydrazide substitutions towards anti-tyrosinase and free radical scavenging activities.
Hassani B; Zare F; Emami L; Khoshneviszadeh M; Fazel R; Kave N; Sabet R; Sadeghpour H
RSC Adv; 2023 Oct; 13(46):32433-32443. PubMed ID: 37942455
[TBL] [Abstract][Full Text] [Related]
6. Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects.
Kontoghiorghes GJ
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902402
[TBL] [Abstract][Full Text] [Related]
7. New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer.
Kontoghiorghes GJ
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430469
[TBL] [Abstract][Full Text] [Related]
8. Questioning Established Theories and Treatment Methods Related to Iron and Other Metal Metabolic Changes, Affecting All Major Diseases and Billions of Patients.
Kontoghiorghes GJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163288
[TBL] [Abstract][Full Text] [Related]
9. New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.
Kontoghiorghes GJ; Kolnagou A; Demetriou T; Neocleous M; Kontoghiorghe CN
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074010
[TBL] [Abstract][Full Text] [Related]
10. Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications.
Kontoghiorghes GJ; Kolnagou A; Kontoghiorghe CN; Mourouzidis L; Timoshnikov VA; Polyakov NE
Medicines (Basel); 2020 Jul; 7(8):. PubMed ID: 32751493
[TBL] [Abstract][Full Text] [Related]
11. Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.
Kontoghiorghes GJ; Kontoghiorghe CN
Cells; 2020 Jun; 9(6):. PubMed ID: 32545424
[TBL] [Abstract][Full Text] [Related]
12. Redox Interactions of Vitamin C and Iron: Inhibition of the Pro-Oxidant Activity by Deferiprone.
Timoshnikov VA; Kobzeva TV; Polyakov NE; Kontoghiorghes GJ
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486511
[TBL] [Abstract][Full Text] [Related]
13. Advances on Chelation and Chelator Metal Complexes in Medicine.
Kontoghiorghes GJ
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260293
[TBL] [Abstract][Full Text] [Related]
14. The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia.
Kontoghiorghes GJ; Kleanthous M; Kontoghiorghe CN
Mediterr J Hematol Infect Dis; 2020; 12(1):e2020011. PubMed ID: 31934321
[TBL] [Abstract][Full Text] [Related]
15. Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration.
Rao SS; Adlard PA
Front Mol Neurosci; 2018; 11():276. PubMed ID: 30174587
[TBL] [Abstract][Full Text] [Related]
16. New developments and controversies in iron metabolism and iron chelation therapy.
Kontoghiorghe CN; Kontoghiorghes GJ
World J Methodol; 2016 Mar; 6(1):1-19. PubMed ID: 27019793
[TBL] [Abstract][Full Text] [Related]
17. Dietary and pharmacological factors affecting iron absorption in mice and man (Comment for a Letter to the editor).
Kontoghiorghe CN; Kolnagou A; Kontoghiorghes GJ
Haematologica; 2016 Mar; 101(3):e120-1. PubMed ID: 26928250
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.
Kontoghiorghe CN; Kontoghiorghes GJ
Drug Des Devel Ther; 2016; 10():465-81. PubMed ID: 26893541
[TBL] [Abstract][Full Text] [Related]
19. Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology.
Kontoghiorghe CN; Kolnagou A; Kontoghiorghes GJ
Molecules; 2015 Nov; 20(11):20841-72. PubMed ID: 26610453
[TBL] [Abstract][Full Text] [Related]
20. Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.
Kontoghiorghes GJ; Neocleous K; Kolnagou A
Drug Saf; 2003; 26(8):553-84. PubMed ID: 12825969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
